(Q38982082)

8 September 2017

title

Basis of HBV persistence and new treatment options (English)

1 reference

8 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201329%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

author name string

Mark Thursz

series ordinal

1

1 reference

8 September 2017

language of work or name

1 reference

27 December 2013

1 reference

8 September 2017

published in

Hepatology international

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201329%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

volume

8 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201329%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

486-491

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201329%20AND%20SRC:MED&resulttype=core&format=json

A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

14 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Virus-like particles in serum of patients with Australia-antigen-associated hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

New insight in the pathobiology of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Molecular genetics of HBV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Control of cccDNA function in hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

The replication cycle of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Understanding the host genetics of chronic hepatitis B and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Heterozygote advantage for HLA class-II type in hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Responses to booster hepatitis B vaccination are significantly correlated with genotypes of human leukocyte antigen (HLA)-DPB1 in neonatally vaccinated adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Lamivudine for patients with chronic hepatitis B and advanced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Stealth and cunning: hepatitis B and hepatitis C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes/macrophages by interfering with JNK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Concerted action of activation-induced cytidine deaminase and uracil-DNA glycosylase reduces covalently closed circular DNA of duck hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-013-9504-6

Hepatitis B virus precore/core variation and interferon therapy

21 January 2018

1 reference

12 December 2020

Effects of structural variations of APOBEC3A and APOBEC3B genes in chronic hepatitis B virus infection

1 reference

12 December 2020

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

1 reference

12 December 2020

Downregulation of TLR7/9 leads to deficient production of IFN-α from plasmacytoid dendritic cells in chronic hepatitis B

1 reference

12 December 2020

Hepatitis B virus markers in Chinese twins

1 reference

12 December 2020

Studies on the risk factors of intrauterine infection of hepatitis B virus

1 reference

12 December 2020